<DOC>
	<DOCNO>NCT02666885</DOCNO>
	<brief_summary>The current trial evaluate integration pretherapeutical FDG-PET/MRI adjuvant radiochemotherapy patient head neck cancer . As secondary hypothesis intention develop multi-parametric decision support system personalise medicine integrate functional imaging , Î³H2AX-analysis genetic information .</brief_summary>
	<brief_title>Personalised Postoperative Radiochemotherapy Patients With Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>locallyadvanced HNSCC ( Oro Hypopharynx ) stage III IV without distant metastasis contraindication PET/MRI contraindication radiochemotherapy inform consent ECOG PS 0/2 Secondary malignancy might influence outcome within 2 year radiochemotherapy HNSCC previous PET/CT induction therapy pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Personalized Medicine</keyword>
	<keyword>Radiation Oncology</keyword>
	<keyword>Functional Imaging</keyword>
	<keyword>Biomarker</keyword>
	<keyword>Decision Support System</keyword>
	<keyword>Radiomics</keyword>
</DOC>